BACKGROUND: The definition of minor ischemic stroke (MIS) is a topic of debate, however, the most accepted definition is a stroke with National Institutes of Health Stroke Scale (NIHSS) ≤ 5. Intravenous thrombolysis (IVT) is a crucial treatment option for acute ischemic stroke (AIS) including: alteplase, recombinant human tissue-type plasminogen activator (r-tPA), and the recently approved tenecteplase. However, there is a debate regarding its safety and efficacy. Therefore, our objective was to determine the safety and efficacy of IVT in treating minor stroke patients (NIHSS ≤ 5). METHODS: Using the search strategy assigned which was based on three keywords: "mild" or "minor", "stroke", and "intravenous thrombolysis", we searched for eligible articles on PubMed, Web of Science, Embase, and Scopus from inception till 10th January 2024. We conducted this meta-analysis using the random effect model to account for the heterogeneity among the studies. For the dichotomous variables, we calculated the odds ratio (OR) from the event and total of these variables. While for the continuous variables, we calculated the mean difference (MD) of these variables. Pooling of OR for the occurrence of events was also conducted. RESULTS: A total of 21 articles with 93,057 patients with MIS were included. The mean age of the participants ranged from 62.3 to 79.6. Most of the included patients had comorbidities such as hypertension, diabetes, previous stroke, smoking, atrial fibrillation, and hyperlipidemia. Of these, 10,850 received IVT while 82,207 did not. The use of IVT was statistically significant associated with 90-day modified Rankin score (mRs) 0-1 when compared with control with OR of 1.67 (95%CI: 1.46, 1.91, p < 0.00001) and was statistically significantly associated with improvement of NIHSS on discharge with OR of 2.19 (95%CI: 1.56, 3.08, p < 0.00001). In terms of safety outcomes, IVT has proven a safe profile, as there was no significant difference in intracranial hemorrhage (ICH) and mortality rates between the IVT and control groups with OR of 1.75 (95CI: 0.95, 3.23, p = 0.07) and 0.93 (95%CI: 0.77, 1.11, p = 0.41), respectively. CONCLUSION: Although some studies have not found any benefits of IVT in MIS patients, a substantial body of literature strongly endorses IVT as an effective and safe treatment for MIS. IVT has been shown to improve the mRs and NIHSS scores at the 90-day mark without an increased risk of ICH or mortality.

Alexandria Main University Hospital Alexandria Egypt

Department for Epileptology Bonn University Bonn Germany

Department of Neurology RWTH Aachen University Pauwels Street 30 Aachen 52074 Germany

Department of Public Health Theodor Bilharz Research Institute Cairo Egypt

Faculty of Medicine Cairo University Cairo Egypt

Faculty of Medicine Masaryk University Brno Czech Republic

Faculty of Medicine New Giza University Cairo Egypt

Faculty of Medicine Suez Canal University Ismailia Egypt

Neuroradiology Department RWTH University Hospital of Aachen Aachen Germany

See more in PubMed

Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority, (in eng). Stroke. 2011;42(12):3651–4. 10.1161/strokeaha.111.635755. PubMed

Zhuo Y, et al. Estimation of stroke severity with National Institutes of Health Stroke Scale grading and retinal features: A cross-sectional study, (in eng). Medicine (Baltimore). 2021;100(31):e26846. 10.1097/md.0000000000026846. PubMed PMC

Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014;60(1):61. 10.1016/j.jphys.2013.12.012. PubMed

Fernandes AP, Jaiswal SK, Yan FL. A new point of consideration for the definition of minor ischemic stroke. Neurosci Med. 2021;12(01):44–54.

Venketasubramanian N, et al. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study), (in eng). Int J Stroke. 2009;4(1):54–60. 10.1111/j.1747-4949.2009.00237.x. PubMed

Fischer U, et al. What is a minor stroke?, (in eng). Stroke. 2010;41(4):661–6. 10.1161/strokeaha.109.572883. PubMed

Crespi V, Braga M, Beretta S, Carolei A, Bignamini A, Sacco S. A practical definition of minor stroke, (in eng). Neurol Sci. 2013;34(7):1083–6. 10.1007/s10072-012-1205-8. PubMed

Li X, Zhao Y, Hu Y, Zhao R, Zhao W. Clinical efficacy of intravenous thrombolysis with alteplase in treatment of elderly patients with minor stroke and its effect on prognosis. Int J Clin Exp Med. 2019;12(7):9019.

Dhamoon MS, et al. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study, (in eng). Stroke. 2009;40(8):2805–11. 10.1161/strokeaha.109.549576. PubMed PMC

Sykora M, et al. Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1, (in eng). Int J Stroke. 2022;17(1):109–19. 10.1177/1747493021991969. PubMed

Saber H, et al. Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States, (in eng). Stroke. 2020;51(11):3241–9. 10.1161/strokeaha.120.030898. PubMed

Romano JG, et al. Predictors of outcomes in patients with mild ischemic stroke symptoms: MaRISS, (in eng). Stroke. 2021;52(6):1995–2004. 10.1161/strokeaha.120.032809. PubMed PMC

Khatri P, et al. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial, (in eng). JAMA. 2018;320(2):156–66. 10.1001/jama.2018.8496. PubMed PMC

Smith EE, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke, (in eng). Stroke. 2011;42(11):3110–5. 10.1161/strokeaha.111.613208. PubMed

Khatri P, Conaway MR, Johnston KC. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke, (in eng). Stroke. 2012;43(2):560–2. 10.1161/strokeaha.110.593897. PubMed PMC

Warner JJ, Harrington RA, Sacco RL, Elkind MSV. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke, (in eng). Stroke. 2019;50(12):3331–2. 10.1161/strokeaha.119.027708. PubMed

Schwamm LH, et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals, (in eng). Circ Cardiovasc Qual Outcomes. 2013;6(5):543–9. 10.1161/circoutcomes.111.000303. PubMed

Asdaghi N, et al. Predictors of thrombolysis administration in mild stroke: Florida-Puerto Rico collaboration to reduce stroke disparities, (in eng). Stroke. 2018;49(3):638–45. 10.1161/strokeaha.117.019341. PubMed PMC

Xiong Y, et al. Intravenous thrombolysis in Chinese patients with mild acute ischemic stroke, (in eng). Ann Transl Med. 2021;9(9):767. 10.21037/atm-21-40. PubMed PMC

Logallo N, Kvistad CE, Naess H, Waje-Andreassen U, Thomassen L. Mild stroke: safety and outcome in patients receiving thrombolysis, (in eng). Acta Neurol Scand Suppl. 2014;198:37–40. 10.1111/ane.12235. PubMed

Pożarowszczyk N, Kurkowska-Jastrzębska I, Sarzyńska-Długosz I, Nowak M, Karliński M. Reliability of the modified Rankin Scale in clinical practice of stroke units and rehabilitation wards, (in eng). Front Neurol. 2023;14:1064642. 10.3389/fneur.2023.1064642. PubMed PMC

Choi JC, et al. Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke, (in eng). J Am Heart Assoc. 2015;4(1):e001306. 10.1161/jaha.114.000596. PubMed PMC

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, (in eng). Int J Surg. 2010;8(5):336–41. 10.1016/j.ijsu.2010.02.007. PubMed

Cumpston M, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019:10(10):ED000142. PubMed PMC

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, (in eng). Eur J Epidemiol. 2010;25(9):603–5. 10.1007/s10654-010-9491-z. PubMed

RoB 2: A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed. PubMed

RevMan: Systematic review and meta-analysis tool for researchers worldwide | Cochrane RevMan. https://revman.cochrane.org/info. Accessed.

OpenMeta[Analyst] -- CEBM @ Brown. http://www.cebm.brown.edu/openmeta/. Accessed.

Urra X, et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis, (in eng). PLoS ONE. 2013;8(3):e59420. 10.1371/journal.pone.0059420. PubMed PMC

Chen W, et al. Intravenous thrombolysis in Chinese patients with different subtype of mild stroke: thrombolysis in patients with mild stroke, (in eng). Sci Rep. 2017;7(1):2299. 10.1038/s41598-017-02579-2. PubMed PMC

Luo X, Huo T, Cao P, Zhao J, Zhang Y, Tan G. Thrombolysis versus nonthrombolyzed in patients with mild strokes and large vessel occlusions: results of a multicenter stroke registration, (in eng). Neurologist. 2024;29(1):31–5. 10.1097/nrl.0000000000000516. PubMed PMC

Ng FC, Coote S, Frost T, Bladin C, Choi PM. Utility of computed tomographic perfusion in thrombolysis for minor stroke, (in eng). Stroke. 2016;47(7):1914–6. 10.1161/strokeaha.116.013021. PubMed

Greisenegger S, Seyfang L, Kiechl S, Lang W, Ferrari J. Thrombolysis in patients with mild stroke: results from the Austrian Stroke Unit Registry, (in eng). Stroke. 2014;45(3):765–9. 10.1161/strokeaha.113.003827. PubMed

W Zhong, Y Zhou, K Zhang, S Yan, J Sun, M Lou. Minor non-disabling stroke patients with large vessel severe stenosis or occlusion might benefit from thrombolysis, (in eng). Brain Sci. 2021;11(7). 10.3390/brainsci11070945. PubMed PMC

Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience, (in eng). Ann Emerg Med. 2005;46(3):243–52. 10.1016/j.annemergmed.2005.02.013. PubMed

Duan C, et al. Outcomes in minor stroke patients treated with intravenous thrombolysis, (in eng). CNS Neurosci Ther. 2023;29(8):2308–17. 10.1111/cns.14164. PubMed PMC

Han Y, et al. Effect of rt-PA intravenous thrombolysis on the prognosis of patients with minor ischemic stroke, (in eng). Neurol Res. 2021;43(8):653–8. 10.1080/01616412.2021.1908672. PubMed

Hsia AW, et al. Prevalence of imaging targets in patients with minor stroke selected for IV tPA treatment using MRI: the treatment of minor stroke with MRI evaluation study (TIMES), (in eng). Neurology. 2021;96(9):e1301-11. 10.1212/wnl.0000000000011527. PubMed PMC

Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM. Intravenous tissue plasminogen activator for patients with minor ischemic stroke, (in eng). J Stroke Cerebrovasc Dis. 2012;21(8):732–6. 10.1016/j.jstrokecerebrovasdis.2011.03.009. PubMed PMC

C Laurencin et al., Thrombolysis for acute minor stroke: outcome and barriers to management. Results from the RESUVAL Stroke Network, (in eng). Cerebrovasc Dis. 2015;40(1–2):3–9. 10.1159/000381866. PubMed

Villringer K, Grittner U, Schaafs LA, Nolte CH, Audebert H, Fiebach JB. IV t-PA influences infarct volume in minor stroke: a pilot study, (in eng). PLoS ONE. 2014;9(10):e110477. 10.1371/journal.pone.0110477. PubMed PMC

Pitaksuteepong P, Anamnart CITY, Udompat P. Effects of intravenous thrombolysis in patients with minor stroke. Int J Stroke. 2020;15(1):178–178.

JSPA Mengel, M Lingel, M Krumbholz, MI Stefanou, F Hennersdorf, U Ernemann, U Ziemann, K Feil, S Poli. Computed tomography perfusion imaging-based intravenous thrombolysis in minor stroke patients. Eur Stroke J. 2022;7:264 PubMed PMC

S Yaghi, SG Keyrouz, A Hinduja. Abstract 2841: intravenous thrombolysis for minor strokes: outcome in a cohort of patients treated through telemedicine. Stroke. 2012;43(suppl_1):A2841-A2841. 10.1161/str.43.suppl_1.A2841.

S Sharma, U Afzal, M Pervez, R Clark, JG Latorre, Z El-Zammar. Abstract 19483: assessment of outcome in patients with acute minor ischemic stroke treated with intravenous TPA. Circulation. 2014;130(suppl_2):A19483-A19483. 10.1161/circ.130.suppl_2.19483.

Abbas A, et al. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: a systematic review and meta-analysis of safety and efficacy. J Stroke Cerebrovasc Dis. 2024;33(7):107704. 10.1016/j.jstrokecerebrovasdis.2024.107704. PubMed

Wang P, et al. Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin, (in eng). Stroke Vasc Neurol. 2021;6(2):187–93. 10.1136/svn-2019-000319. PubMed PMC

Rota E, Morelli N, Immovilli P, Cerasti D, Zini A, Guidetti D. “Minor” stroke: not a minor, still open question, (in eng). J Thromb Thrombolysis. 2020;49(1):132–5. 10.1007/s11239-019-02001-w. PubMed

Tu WJ, Xu Y, Liu Y, Li J, Du J, Zhao J. Intravenous Thrombolysis or Medical Management for Minor Strokes, (in eng). Thromb Haemost. 2023;123(7):734–43. 10.1055/s-0043-1768150. PubMed

You S, et al. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis, (in eng). Stroke Vasc Neurol. 2018;3(1):22–7. 10.1136/svn-2017-000106. PubMed PMC

Muruet W, Rudd A, Wolfe CDA, Douiri A. Long-term survival after intravenous thrombolysis for ischemic stroke: a propensity score-matched cohort with up to 10-year follow-up, (in eng). Stroke. 2018;49(3):607–13. 10.1161/strokeaha.117.019889. PubMed PMC

Schmitz ML, et al. Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study, (in eng). Stroke. 2014;45(10):3070–2. 10.1161/strokeaha.114.006570. PubMed

Berge E, et al. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial, (in eng). Lancet Neurol. 2016;15(10):1028–34. 10.1016/s1474-4422(16)30139-9. PubMed

Kim DH, Lee DS, Nah HW, Cha JK. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke, (in eng). BMC Neurol. 2018;18(1):30. 10.1186/s12883-018-1033-4. PubMed PMC

Strambo D, et al. Defining minor symptoms in acute ischemic stroke, (in eng). Cerebrovasc Dis. 2015;39(3–4):209–15. 10.1159/000375151. PubMed

Liu D, et al. DWI lesion patterns predict outcome in stroke patients with thrombolysis, (in eng). Cerebrovasc Dis. 2015;40(5–6):279–85. 10.1159/000441153. PubMed PMC

Rosso C, et al. Tissue at risk in the deep middle cerebral artery territory is critical to stroke outcome, (in eng). Neuroradiology. 2011;53(10):763–71. 10.1007/s00234-011-0916-5. PubMed

Kawano H, Hirano T, Inatomi Y, Terasaki T, Yonehara T, Uchino M. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis, (in eng). Cerebrovasc Dis. 2010;30(3):230–6. 10.1159/000317183. PubMed

Logallo N, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial, (in eng). Lancet Neurol. 2017;16(10):781–8. 10.1016/s1474-4422(17)30253-3. PubMed

Kvistad CE, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial, (in eng). Lancet Neurol. 2022;21(6):511–9. 10.1016/s1474-4422(22)00124-7. PubMed

Campbell BCV, et al. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial, (in eng). JAMA. 2020;323(13):1257–65. 10.1001/jama.2020.1511. PubMed PMC

Menon BK, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial, (in eng). Lancet. 2022;400(10347):161–9. 10.1016/s0140-6736(22)01054-6. PubMed

Katsanos AH, et al. Off-label use of tenecteplase for the treatment of acute ischemic stroke: a systematic review and meta-analysis, (in eng). JAMA Netw Open. 2022;5(3):e224506. 10.1001/jamanetworkopen.2022.4506. PubMed PMC

E Berge et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke, (in eng), Eur Stroke J. 2021;6(1):I-lxii. 10.1177/2396987321989865. PubMed PMC

Powers WJ, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, (in eng). Stroke. 2019;50(12):e344-418. 10.1161/str.0000000000000211. PubMed

Davis SM, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial, (in eng). Lancet Neurol. 2008;7(4):299–309. 10.1016/s1474-4422(08)70044-9. PubMed

Albers GW, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study, (in eng). Ann Neurol. 2006;60(5):508–17. 10.1002/ana.20976. PubMed

Ma H, et al. Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome, (in eng). Int J Stroke. 2015;10(4):565–70. 10.1111/ijs.12203. PubMed

Yaghi S, Eisenberger A, Willey JZ. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment, (in eng). JAMA Neurol. 2014;71(9):1181–5. 10.1001/jamaneurol.2014.1210. PubMed PMC

Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications, (in eng). J Neurol Neurosurg Psychiatry. 2015;86(1):87–94. 10.1136/jnnp-2014-308327. PubMed

Seners P, Baron JC. Revisiting ‘progressive stroke’: incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke, (in eng). J Neurol. 2018;265(1):216–25. 10.1007/s00415-017-8490-3. PubMed

Qin B, Zhang Y, Liang S, Liang H, Tang S, Liang Z. Endovascular treatment versus medical management for mild stroke with acute anterior circulation large vessel occlusion: a meta-analysis, (in eng). J Neurointerv Surg. 2023;15(e3):e475–83. 10.1136/jnis-2022-019959. PubMed